Angola vs Madagascar: Tuberculosis prevalence rate
Tuberculosis prevalence rate over time
- Angola
- Madagascar
How they compare
Madagascar currently reports 428 per 1000,000 population, WHO against 413 per 1000,000 population, WHO in Angola, a difference of 15 per 1000,000 population, WHO.
Across all 22 years both countries report, Madagascar has been ahead every year.
Angola ranks 17th and Madagascar ranks 16th of 53 countries.
Madagascar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 385.3 per 1000,000 population, WHO | 732.5 per 1000,000 population, WHO | 347.2 per 1000,000 population, WHO | Madagascar |
| 2000s | 326.7 per 1000,000 population, WHO | 509.9 per 1000,000 population, WHO | 183.2 per 1000,000 population, WHO | Madagascar |
| 2010s | 387 per 1000,000 population, WHO | 433.5 per 1000,000 population, WHO | 46.5 per 1000,000 population, WHO | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis prevalence rate, Angola or Madagascar?
- Madagascar, at 428 per 1000,000 population, WHO against 413 per 1000,000 population, WHO in Angola as of 2011.
- What is the difference in tuberculosis prevalence rate between Angola and Madagascar?
- 15 per 1000,000 population, WHO, with Madagascar ahead.
- How many years of comparable data are there for Angola and Madagascar?
- 22 years are reported by both, from 1990 to 2011.
- How do Angola and Madagascar rank globally for tuberculosis prevalence rate?
- Angola ranks 17th and Madagascar ranks 16th of 53 countries.
- Where does this data come from?
- World Health Organization, Global Tuberculosis Control Report, published as Tuberculosis prevalence rate (per 1000,000 population, WHO). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The number of cases of tuberculosis (all forms) in a population at a given point in time (the middle of the calendar year), expressed as the rate per 100 000 population. It is sometimes referred to as "point prevalence". Estimates include cases of TB in people with HIV. Published values are rounded to three significant figures. Uncertainty bounds are provided in addition to best estimates.